Pricing Log in Create free account

Enveric Biosciences, Inc. (ENVB) vs NeuroSense Therapeutics Ltd. (NRSN)

Enveric Biosciences, Inc. and NeuroSense Therapeutics Ltd. are both Biotechnology companies. Enveric Biosciences, Inc. and NeuroSense Therapeutics Ltd. are of similar size ($6.2M and $6.0M). Across the 7 metrics below, NeuroSense Therapeutics Ltd. leads on 4 and Enveric Biosciences, Inc. on 3.

Valuation

Metric ENVB NRSN Biotechnology median
P/E n/m n/m 8.50
P/S 0.16 n/m 9.71
P/B 0.68 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.29 n/m 0.64
EV/Sales (0.07) n/m 9.21
Earnings yield (481.51%) (406.90%) (33.15%)
Free cash flow yield (193.82%) (444.35%) (25.50%)

Profitability

Metric ENVB NRSN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (235.48%) 0.00% (56.36%)
Return on assets (193.53%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENVB NRSN Biotechnology median
Revenue growth (TTM) (13.93%) — 6.02%
EPS growth (last fiscal year) 84.14% 18.52% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENVB NRSN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.21 0.28 4.72
Net debt to EBITDA 0.55 0.01 0.96

Dividend

Metric ENVB NRSN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENVB NRSN Biotechnology median
Market cap 6.22m 6.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack